Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Q3 2022 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Reata Pharmaceuticals Third Quarter 2022 Financial Results and Update on Development Programs Conference Call.

Related Keywords

United States ,Japan ,China ,Philadelphia ,Pennsylvania ,Colin Meyer ,Seemi Khan ,Madhu Kumar ,Yigal Nochomovitz ,Manmeet Soni ,Silicon Valley Bank ,University Of South Florida ,Reata Pharmaceuticals Third Quarter ,Jude Children Research Hospital ,Goldman Sachs ,Nasdaq ,Reata Pharmaceuticals Inc ,National Cancer Institute On Unsplash ,Development Programs Conference Call ,Citigroup ,Reata Pharmaceuticals ,Call Transcript November ,Development Programs Conference ,National Cancer Institute ,Warren Huff ,Chief Executive Officer ,Chief Innovation Officer ,Chief Medical Officer ,Dawn Bir ,Chief Commercial ,Prescription Drug User Fee Act ,Marketing Authorization Application ,Autosomal Dominant Polycystic Kidney Disease ,Kyowa Kirin ,Ataxia Rating Scale ,Jude Children ,Research Hospital ,South Florida ,